Trial & Business Updates: 8/1/2000

Printer Friendly Version

Priority Lists

Disease Committee	Last Changed
Breast Cancer	11/1/23
Cancer Care Delivery	9/1/22
comboMATCH	12/1/23
Early Therapeutics & Rare Cancers	12/1/23
Gastrointestinal Cancer	12/1/23
Genitourinary Cancer	12/1/23
Immunomolecular Therapeutics	6/15/20
Leukemia	9/17/24
Lung Cancer	12/1/23
LungMAP	9/27/24
Lymphoma	1/17/24
Melanoma	4/18/22
Myeloma	4/1/24
Other	2/1/14
Palliative and End of Life Care Committee	11/1/20
Prevention & Epidemiology	7/1/24
Symptom Control and Quality of Life	4/1/23

Protocol Posting of 8/1/2000

Activations
Closures
Amendments, Revisions, Memoranda
Other New Items

Activations

Closures

Amendments, Revisions, Memoranda

SWOG-8947Ancillary

Central Lymphoma Serum Repository Protocol

Study Coordinator(s)	Richard I. Fisher, M.D.
Participants	Members, Medical Oncologists, Pathologists, NCORP

Other New Items

IP - Pts Must Be Informed
AC - Consent Must Be Amended
CBR - No Registration Allowed until IRB Review
RC - Formal Re-consent Required
FBR - Full Board Review Required
ER - Expedited Review Acceptable
NR - No IRB Review Required